Comprehensive Clinical Treatise: The Multifaceted Impact of Cognitive Behavioral Therapy on Late-LifeDepression Management

Abstract

Late-life depression (LLD) represents an escalating global public health crisis situated at the convergence of psychiatric morbidity, neurodegenerative vulnerability, age-related somatic decline, and structural socio-environmental shifts. While pharmacological agents historically served as the default clinical countermeasure, their therapeutic index in geriatric cohorts is severely compromised by age altered pharmacokinetics, multi-systemic adverse drug profiles, toxic polypharmacy, and high rates of treatment resistance.
This comprehensive clinical treatise examines Cognitive Behavioral Therapy (CBT) as an empirical, non-pharmacological benchmark for managing depression in patients aged 65 and older. Integrating structural data across clinical, neurobiological, and operational domains, this review details the specific methodological modifications required to align CBT with age-related cognitive changes, evaluates its underlying neurological mechanisms, and assesses its long-term durability and economic sustainability.
Ultimately, this analysis presents an evidence-based roadmap for integrating individual, group, and digital CBT paradigms into primary, secondary, and institutional healthcare infrastructures, advocating for a personalized, precision-oriented approach to geriatric mental health.